Affiliation:
1. Orenburg State Medical University; Orenburg Regional Clinical Hospital № 2
2. Orenburg State Medical University
Abstract
Medullary thyroid cancer (MRSH) has a high malignant potential in the vast majority of cases, but in some patients with MRSH is characterized by a sluggish, non-aggressive course, when patients with the presence of proven medullary carcinoma or distant metastases and / or relapse, can live without progression for a sufficiently long time. Such a course of a malignant tumor is called indolent. The article presents a clinical case of diagnosis and treatment of indolent primary MRSH in a patient with a duration of the disease of 11 years. Shows some features of the dynamics of the level of basal calcitonin and cancer-embryonic antigen (CEA), ultrasound characteristics and data of fine-needle puncture biopsy of the tumor. The phenomenon of indolent course of MRSH characterized, as a rule, by a high malignant potential, is probably due to the biological characteristics of the tumor and requires further research.
Publisher
Endocrinology Research Centre
Reference15 articles.
1. Gazizova D, Beltsevich D. Diagnostics of medullary thyroid cancer. Vrach. 2013;11:8-9. (In Russ.).
2. Gazizova DO, Beltsevich DG, Tiulpakov AN, et al. Diagnosis of medullary thyroid cancer and prognostic factors of disease aggressiveness. Endocrine Surgery. 2013;4:4-13. (In Russ.). doi: https://doi.org/10.14341/serg201344-13
3. Pinsky SB, Beloborodov VA, Dvornichenko VV, Batoroev YuK. Hereditary medullary thyroid cancer. Volga Oncological Bulletin. 2019;10(3):33-39. (In Russ.).
4. Elisei R, Pinchera A. Advances in the follow-up of differentiated or medullary thyroid cancer. Nat Rev Endocrinol. 2012;8(8):466-475. doi: https://doi.org/10.1038/nrendo.2012.38
5. Xu L, Wang W-B, Zhao Y-P, et al. Medullary thyroid carcinoma with nodular goiter carries an excellent prognosis. J Surg Oncol. 2012;106(2):169-173. doi: https://doi.org/10.1002/jso.23070